This excerpt taken from the GIVN 6-K filed May 8, 2007.
This excerpt taken from the GIVN 6-K filed Nov 2, 2006.
Third Quarter and Recent Highlights
In late October, the company received the CE Mark to market PillCam(TM) COLON throughout the European Union.
First Coast Service Options, Inc., which administers Florida and Connecticut Medicare, designated PillCam ESO as a diagnostic tool for patients who are unable to undergo conventional endoscopy or are diagnosed with portal hypertension and require immediate evaluation of esophageal varices. Over 3 million individuals will now have access to PillCam ESO under this designation.
Nine Month Financial Results
For the nine month period ended September 30, 2006, sales were $67.6 million compared to $62.4 million in the same period in 2005. Gross profit for the nine month period was 74.9% compared to 74.2% in 2005. On a GAAP basis, net loss for the first nine months of 2006 was $3.0 million or $0.10 per share, compared to net income of $2.8 million, or $0.095 per share, on a fully diluted basis for the same period in 2005. The nine month period ended September 30, 2006 includes the impact of $4.1 million in expenses due to the adoption of FAS 123R. The Company reported non-GAAP net income of $1.2 million, or $0.04 per share, on a diluted basis in the nine months of 2006.